Back to search
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxsta…
Aim: to compare the treatment effects of Bisoprolol (beta 1 receptor specific beta blocker (BB)) and Verapamil (cardio-specific calcium channel blockers (CCB))…
This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-o…
The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (H…